In 2003 Novartis had been collaborating with Regeneron Pharmaceuticals to test Regeneron's interleukin-1 blocker in rheumatoid arthritis.
Then she heard Regeneron Pharmaceuticals was testing an experimental drug that might help.
This includes the team of Regeneron Pharmaceuticals and Sanofi, Amgen, and Pfizer.
FORBES: Merck's Big Vytorin Study Could Change Rules For New Cholesterol Drugs
But the landscape changed a year ago when the FDA approved yet another drug for wet AMD, Eylea, which is sold by Regeneron Pharmaceuticals.
The majority of analysts (53.8%) rate Regeneron Pharmaceuticals as a buy.
Their returns this year range from the 57% of corporate information-data-services provider Teradata ( TDC), to 149% for drug designer and manufacturer Regeneron Pharmaceuticals ( REGN).
FORBES: 10 Companies That Prove Stock Picking Is Still Alive
Now comes a new glimmer of hope: a hunger-fighter called Axokine, from Regeneron Pharmaceuticals (nasdaq: REGN - news - people ) of Tarrytown, N.
In 2003 Novartis had been collaborating with Regeneron Pharmaceuticals (nasdaq: REGN - news - people ) to test Regeneron's interleukin-1 blocker in rheumatoid arthritis.
The companies that experienced the reductions are: Gilead Sciences Inc. ( GILD), Biogen Idec Inc. ( BIIB), Pall Corp. ( PLL), Onyx Pharmaceuticals ( ONXX) and Regeneron Pharmaceuticals ( REGN).
FORBES: Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter
If this medicine doesn't pan out, the next competitor to Avastin is VEGF-Trap, a treatment that Sanofi is developing with Regeneron Pharmaceuticals (nasdaq: REGN - news - people ).
Among the largest underlying components of IJH, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is up about 0.7%, HollyFrontier Corp. ( NYSE: HFC) is up about 0.3%, and AMETEK, Inc. ( NYSE: AME) is up by about 0.5%.
Among the largest underlying components of IJK, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is down about 5.4%, Equinix Inc ( NASD: EQIX) is down about 1.2%, and HollyFrontier Corp. ( NYSE: HFC) is up by about 1%.
FORBES: iShares S&P MidCap 400 Growth Index Fund Experiences Big Outflow
Among the largest underlying components of IJH, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is up about 0.2%, HollyFrontier Corp. ( NYSE: HFC) is up about 0.7%, and AMETEK, Inc. ( NYSE: AME) is lower by about 0.3%.
Among the largest underlying components of IJH, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is off about 0.8%, HollyFrontier Corp. ( NYSE: HFC) is down about 2%, and Equinix Inc ( NASD: EQIX) is up by about 0.1%.
FORBES: IJH, REGN, HFC, EQIX: Large Outflows Detected at ETF
Among the largest underlying components of XBI, in trading today Dendreon Corp ( NASD: DNDN) is up about 3.5%, Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is up about 0.5%, and Incyte Corporation ( NASD: INCY) is higher by about 0.9%.
Among the largest underlying components of IJH, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is up about 0.6%, HollyFrontier Corp. ( NYSE: HFC) is up about 0.6%, and Equinix Inc ( NASD: EQIX) is lower by about 0.6%.
Among the largest underlying components of MDY, in trading today Vertex Pharmaceuticals, Inc. ( NASD: VRTX) is up about 0.6%, Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is up about 0.2%, and Equinix Inc ( NASD: EQIX) is lower by about 0.9%.
Among the largest underlying components of IJH, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is off about 1.2%, Vertex Pharmaceuticals, Inc. ( NASD: VRTX) is up about 0.5%, and Equinix Inc ( NASD: EQIX) is lower by about 1.6%.
Among the largest underlying components of IJH, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is down about 3.9%, Equinix Inc ( NASD: EQIX) is up about 5.9%, and Vertex Pharmaceuticals, Inc. ( NASD: VRTX) is lower by about 0.8%.
Among the largest underlying components of MDY, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is up about 3%, Vertex Pharmaceuticals, Inc. ( NASD: VRTX) is up about 1.1%, and Equinix Inc ( NASD: EQIX) is up by about 2%.
Among the largest underlying components of XBI, in trading today Dendreon Corp ( NASD: DNDN) is down about 2.9%, Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is off about 0.1%, and Amylin Pharmaceuticals, Inc. ( NASD: AMLN) is lower by about 1.9%.
Among the largest underlying components of XBI, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is up about 2.6%, Amylin Pharmaceuticals, Inc. ( NASD: AMLN) is up about 0.7%, and Medivation Inc ( NASD: MDVN) is lower by about 0.5%.
Among the largest underlying components of IJH, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is down about 0.9%, Equinix Inc ( NASD: EQIX) is off about 0.6%, and Vertex Pharmaceuticals, Inc. ( NASD: VRTX) is higher by about 0.7%.
Among the largest underlying components of IJR, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is off about 1.5%, Questcor Pharmaceuticals Inc ( NASD: QCOR) is off about 0.8%, and HMS Holdings Corp ( NASD: HMSY) is lower by about 0.5%.
FORBES: iShares S&P SmallCap 600 Index Fund Experiences Big Inflow
Among the largest underlying components of MDY, in trading today Green Mountain Coffee Roasters Inc ( NASD: GMCR) is up about 0.2%, Monster Beverage Corp ( NASD: MNST) is up about 1.3%, and Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is higher by about 0.7%.
Late last week, the FDA approved a new med called Eylea, which is made by Regeneron Pharmaceuticals ( see this), an upstart with board members that include such heavy hitters as former Merck ceo Roy Vagelos and, as of this morning, Marc Tessier-Lavigne, a former executive vp and chief scientific officer at Genentech, who is currently president of Rockefeller University, the medical research institution ( read here).
Among the largest underlying components of XBI, in trading today Biomarin Pharma ( NASD: BMRN) is up about 1.8%, Regeneron Pharmaceutical ( NASD: REGN) is up about 0.4%, and Spectrum Pharmaceuticals ( NASD: SPPI) is up by about 4%.
Among the largest underlying components of XBI, in trading today Alexion Pharmaceuticals Incorporated ( NASD: ALXN) is up about 4.6%, Regeneron Pharmaceutical Incorporated ( NASD: REGN) is down about 3.4%, and Biomarin Pharma Incorporated ( NASD: BMRN) is lower by about 0.8%.
应用推荐